Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits?

M.L. Kimman*, A.C. Voogd, C.D. Dirksen, P.R.J. Falger, P.S.G.J. Hupperets, K.B.I.M. Keymeulen, M.H. Hebly, C.J.G. Dehing-Oberije, P. Lambin, L.J. Boersma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

35 Downloads (Pure)


Follow-up after curative treatment for breast cancer consists of frequent outpatient clinic visits, scheduled at regular intervals. Its aim is primarily to detect local disease recurrence, or a second primary breast cancer, but also to provide information and psychosocial support. The cost-effectiveness of these frequent visits is being questioned however, leading to a search for less intensive follow-up strategies, such as follow-up by the general practitioner, patient-initiated or nurse-led follow-up or contact by telephone. These strategies are generally considered to be safe, but they are not yet widely accepted in clinical practice. Since brief interventions based on self-education and information have been shown to be able to improve quality of life, we hypothesise that these interventions may lead to a better acceptance of reduced follow-up by both patients and professionals.
Original languageEnglish
Pages (from-to)647-653
JournalEuropean Journal of Cancer
Issue number4
Publication statusPublished - 1 Jan 2007

Cite this